Watermark
Go to Asia edition

Warner Chilcott Considers Repricing Counter

Warner Chilcott wasn’t able to secure approval for the proposed repricing on its $2.1 billion term loan to finance its acquisition of Procter & Gamble’s prescription drug unit.

  • 26 Jan 2010

--Katherine Greene

Warner Chilcott wasn’t able to secure approval for the proposed repricing on its $2.1 billion term loan to finance its acquisition of Procter & Gamble’s prescription drug unit. The repricing was launched a week ago and lenders were given until today to make a decision. ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Or sign up for a trial to gain full access to the entire site for a limited period.

Free Trial
Log in

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

GlobalCapital European securitization league table

Rank Lead Manager/Arranger Total Volume $m No. of Deals Share % by Volume
View full table
1 BNP Paribas 12,508 23 18.18
2 Bank of America Merrill Lynch (BAML) 8,059 25 11.72
3 Lloyds Bank 5,761 18 8.38
4 Citi 5,606 15 8.15
5 JP Morgan 5,007 7 7.28

Bookrunners of Global Structured Finance

Rank Lead Manager Amount $m No of issues Share %
View full table
For detailed analysis: Dealogic
  • Last updated
  • Today
1 Citi 95,847.77 272 11.13%
2 Bank of America Merrill Lynch 80,029.51 227 9.30%
3 JPMorgan 72,172.60 208 8.38%
4 Wells Fargo Securities 69,859.54 198 8.12%
5 Credit Suisse 58,056.32 149 6.74%